🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10259+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10259 recruiting trials

NAEnrolling by InvitationNCT07250412

The Accuracy Of 3D Color Ultrasonography for Detecting the Degree of Placenta Accreta Spectrum Invasion

🏥 Sohag University📍 1 site📅 Started Sep 2025View details ↗
Phase 1Enrolling by InvitationNCT07113743

Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease

👨‍⚕️ Elizabeth M Kang, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Sep 2025View details ↗
Phase 1RecruitingNCT04789148

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

👨‍⚕️ Elizabeth A Lawson, MD, MMSc, Massachusetts General Hospital📍 1 site📅 Started Sep 2025View details ↗
Phase 3RecruitingNCT07029828

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 4 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07174726

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

👨‍⚕️ None None📍 6 sites📅 Started Sep 2025View details ↗
Phase 3Enrolling by InvitationNCT07136766

An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product

🏥 Good Molecules, LLC📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06599762

Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia

🏥 University of Manitoba📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT07332117

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

🏥 Royal Brompton & Harefield NHS Foundation Trust📍 1 site📅 Started Sep 2025View details ↗
Phase 4RecruitingNCT06824103

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 19 sites📅 Started Sep 2025View details ↗
RecruitingNCT06970028

Somatosensory Phenotyping of ADPKD

👨‍⚕️ Jan de Hoon, MD, PhD, MSc, UZ Leuven📍 1 site📅 Started Sep 2025View details ↗
NAEnrolling by InvitationNCT07102849

Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study

👨‍⚕️ Bhavisha A Patel, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Sep 2025View details ↗
NARecruitingNCT07292246

A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)

👨‍⚕️ Vasileios Kalles, MD, MSc, PhD, FEBS, Mediterraneo Hospital📍 1 site📅 Started Sep 2025View details ↗
Phase 1, PHASE2RecruitingNCT06833320

Propranolol Treatment for Postoperative Chylothorax

👨‍⚕️ June Wu, MD, Columbia University Irving Medical Center/ New York Presbyterian hospital📍 1 site📅 Started Sep 2025View details ↗
Phase 3RecruitingNCT07011719

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

👨‍⚕️ Medical Director, Arcus Biosciences📍 29 sites📅 Started Sep 2025View details ↗
Phase 1, PHASE2RecruitingNCT06814496

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

👨‍⚕️ Charles Hsu, MD, University of Arizona📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07305974

A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy

🏥 Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.📍 1 site📅 Started Sep 2025View details ↗
NARecruitingNCT06893510

Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia

👨‍⚕️ Ergül Aslan, Prof. Dr., İstanbul University-Cerrahpaşa📍 1 site📅 Started Sep 2025View details ↗
Enrolling by InvitationNCT06841341

Electrophysiology and Ultrasound of Respiratory Muscles and Respective Nerves to Predict Respiratory Insufficiency in ALS

🏥 Jagiellonian University📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07091734

Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024

👨‍⚕️ Elif Oral, MD, University of Michigan📍 1 site📅 Started Sep 2025View details ↗
Phase 3RecruitingNCT07139873

A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)

👨‍⚕️ Study Director, Dizal (Jiangsu) Pharmaceutical Co., Ltd.📍 2 sites📅 Started Sep 2025View details ↗
← PreviousPage 67 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →